Epitomee Med (EPIT) Stock Statistics & Valuation Metrics

Epitomee Med has a market cap or net worth of 260.38M. The enterprise value is ―.

Epitomee Med has 29,816,158 shares outstanding. The number of shares has decreased by -2.65% in one year.

Epitomee Med’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.

The current PE Ratio of Epitomee Med is ―. Epitomee Med’s PEG ratio is ―.

In the last 12 months, Epitomee Med had revenue of 10.00M and earned -5.68M in profits. Earnings per share was -0.19.

In the last 12 months, operating cash flow was -2.25B and capital expenditures -783.13M, giving a free cash flow of -3.04B billion.

Epitomee Med pays an annual dividend of ―, resulting in a dividend yield of ―

Epitomee Med upcoming earnings date is ―, TBA Not Confirmed.

Epitomee Med as a current ratio of ―, with Debt / Equity ratio of ―

In the past 12 months, Epitomee Med has paid 0.00 in taxes.

Epitomee Med EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.

Epitomee Med has 29.14M in cash and marketable securities with 4.22M in debt, giving a net cash position of -24.92M billion.

Gross margin is ―, with operating margin of ―, and net profit margin of ―.

The average price target for Epitomee Med is ―, which is 11.43% higher than the current price. The consensus rating is ―